A new vaccine approach to HIV that stimulates a set of rare immune cells showed 97% success at targeting those cells in its first tests in humans.
HIV vaccine stimulates 'rare immune cells' in early human trials : Read more
HIV vaccine stimulates 'rare immune cells' in early human trials : Read more